✨ Onyx Summary
A new Harris Poll survey commissioned by ImmunityBio finds that most U.S. patients with non-muscle invasive bladder cancer receive limited discussion of treatment options despite heavy reliance on healthcare providers for guidance, and many seek alternatives to chemotherapy, including immunotherapy.
The results underscore a communication gap in
✨ Onyx Summary
Legend Biotech opened a new 31,000-square-foot R&D facility in Philadelphia to support expansion of its next-generation cell therapy pipeline, adding approximately 55 research staff and strengthening its U.S. footprint.
The site enhances the company’s innovation capabilities alongside existing New Jersey operations and aligns
✨ Onyx Summary
enGene priced its underwritten public offering of 12.6 million common shares and 2.7 million pre-funded warrants, raising approximately $130 million in gross proceeds, with a 30-day overallotment option available to underwriters.
The financing, conducted under the company’s effective shelf registration, is expected to close on
✨ Onyx Summary
Guardant Health launched the 34-member Single Namespace Working Group to establish an open standard for exabyte-scale data interoperability, creating a unified framework that links globally distributed data into a single namespace.
The consortium’s transition to OASIS positions the standard for broad adoption, aiming to streamline data access